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Abstract:  Abnormalities  in  mineral-dependent  antioxidant  enzymes  in  children  with  autism  raise 
interest in the determination of trace mineral status in this population. A cross sectional investigation 
of red cell mineral levels was carried out among 20 children with autism and 15 controls. Children 
with autism demonstrated significantly lower red cell selenium (p<0.0006) and higher molybdenum 
(p<0.01)  than  the  controls.  There  was  a  trend  toward  lower  red  cell  zinc  and  higher  cobalt  and 
vanadium, among the children with autism. There were no differences in red cell levels of chromium, 
copper, manganese, or magnesium. These findings confirm an earlier report of low red cell selenium in 
autism and support a role for decreased trace mineral status in oxidative stress in autism through 
alteration of selenium-dependent antioxidant enzymes and increased lipid peroxidation.  
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INTRODUCTION 
 
  Although  lower  dietary  intakes  of  trace  minerals 
are reported in children with autism
[1], little is known 
about concentrations of trace minerals in blood. Red-
cell mineral analysis provides an enhanced diagnostic 
tool  for  the  assessment  of  childhood  mineral  status. 
This study sought to measure red-cell trace minerals in 
children  with  autism  compared  to  age-matched 
controls. 
  Specific biochemical abnormalities in children with 
autism  particularly  heighten  interest  in  selenium  and 
zinc  status.  Increased  lipid  peroxidation
[2]  and 
decreased glutathione peroxidase (GSHPx) in red-cells 
of children with autism
[3,4] suggest possible deficiency 
of  selenium,  borderline  status  of  which  is  associated 
with reduced GSHPx activity.  
  Superoxide  dismutase  (SOD),  another  important 
anti-oxidant enzyme, is zinc-dependent. Red-cell SOD 
activity  is  depressed  in  children  with  autism
[4]  and 
marginal  deficiency  of  zinc  in  humans  is  associated 
with  lower  SOD  activity
[5].  A  retrospective  study 
reported subnormal plasma zinc concentrations in forty 
percent of children with autism
[6]. 
  
MATERIALS AND METHODS 
 
Study  participants:  The  participants  in  the  study 
included 20 children  with a  recent prior diagnosis of 
autism  (age:  3.90±1.68;  4  female,  16  male)  and  15 
healthy  control  children  (age:  3.87±1.06; 9  female,  6 
male).  Developmental  pediatricians  and  psychologists 
in  the  various  regions  of  participant  residence  in 
accordance with DSM-IV criteria carried out diagnosis 
of  autism.  Inclusion  criteria  for  the  study  required 
verbal  parental  confirmation  of  diagnosis.  Hard  copy 
confirmation of diagnosis was not collected.  
  Additional study criteria included a history of no 
specialty  diets  (gluten-free/casein-free),  no  regular 
nutritional  supplements  or  pharmaceutical  medication 
intake and no recent illness for the two weeks prior to 
blood collection.  
 
Study design: This study was designed as a one-time 
cross-sectional comparison of red-cell concentrations of 
trace elements to assess potential differences between 
children with autism and healthy controls of the same 
age.  A  five  day  food  diary  was  requested  for  all 
participants.  However,  compliance  and  quality  of 
record  keeping  were  too  poor  to  provide  reliable 
comparative data. Human ethics approval was carried 
out  by  IRB  Institutional  Review  Board  Services, 
Aurora, Ontario, Canada. 
 
Sample  collection  and  treatment:  Morning  fasting 
blood samples were collected in lithium-heparin trace-
element  free  evacuated  tubes.  The  samples  were 
centrifuged at 24000 for 10 minutes. White cells and 
plasma were removed from the samples. Red cells were 
transferred  by  trace  element-free  pipette  to  trace 
element-free travel tubes and held at room temperature 
pending   transportation  by   overnight   courier   to  the  Am. J. Biochem. & Biotech., 4 (2): 101-104, 2008 
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Table 1: Red blood cell trace elements 
  Autistic Children (n=20)   Control Children (n=15)  P value 
  (4 Female,16 Male)  (9 Female, 6 Male) 
  Mean (±SD)  Mean (±SD) 
Age (years)   3.90 (1.68)  3.87 (1.06)   
Cobalt (nmol/L)   3.03 (1.85)  2.36 (0.81)  0.07* 
Chromium (nmol/L)   25.68 (12.10)  21.15 (13.31)  0.15 
Copper (umol/L)  14.38 (1.39)  14.90 (2.29)  0.22 
Magnesium (mmol/L)  2.16 (0.21)  2.22 (0.2)  0.2 
Manganese (nmol/L)  407.40 (92.85)  417.60 (136.73)  0.4 
Molybdenum (nmol/L)  12.62 (9.93)  6.27 (1.42)  0.01** 
Selenium (umol/L)  3.12 (0.54)  3.67 (0.38)  0.0006*** 
Vanadium (nmol/L)  2.07 (1.23)  1.62 (0.59)  0.08* 
Zinc (umol/L)  134.95 (23.94)  148.27 (17.09)  0.08* 
*p<0.1    **p<0.01    ** *p<0.001 
 
London  Health  Sciences  Trace  Elements  Laboratory, 
London,  Ontario  for  analysis.  Erythrocytes  were 
digested with nitric acid and hydrogen peroxide, diluted 
with  purified  water  and  analyzed  on  an  ICP-MS,  an 
inductively coupled plasma mass spectometer (Finnigan 
MAT Element High Resolution). The raw data from the 
digested samples was compared to standards of known 
concentration for the elements to be measured, to give 
final  concentrations.  Blood  reference  controls  with 
know values were also analyzed to verify the method. 
 
Statistical  analysis:  Comparison  of  red-cell  trace 
mineral levels between autistic and control children was 
carried using the Student’s t test with significance set at 
0.05. Important trends were identified where statistical 
p values fell between 0.05 and 0.1. 
 
RESULTS AND DISCUSSION 
 
  Red-cell levels of trace minerals for children with 
and  without  autism  are  summarized  in  Table  1.  The 
children with autism demonstrated significantly lower 
selenium levels and a trend toward lower zinc status. 
However, molybdenum levels were significantly higher 
for children with autism, who also demonstrated a trend 
toward higher cobalt and vanadium levels. There were 
no  significant  differences  or  trends  in  chromium, 
copper, manganese and magnesium levels.  
  The current study found lower red-cell selenium in 
children  with  autism  versus  age-matched  controls 
(p<0.001),  consistent  with  an  earlier  report  of  lower 
red-cell selenium in children with autism
[7].  
  Selenium  plays  an  important  role  in  the  redox 
reactions  of  metallothionein  and  glutathione
[8,9]. 
Selenium  counteracts  the  oxidative  effects  of  various 
heavy metals by seqestering them in nontoxic complex, 
as in in brain
[10]. Selenium is an essential component of 
the  anti-oxidant  selenoprotein,  GSHPx.  Thus,  by 
diverse mechanisms, lower selenium status modulates 
oxidative stress, which is reportedly greater in autism
[11-
14].  
  Greater  oxidative  stress  in  autism manisfests 
as increased  peroxidation  of  lipid  biomolecules, 
measurable in red-cells
[2] and urine
[15,16]. This specific 
biochemical  end-point  is  particularly  sensitive  to 
selenium  status.  As  referenced  previously,  even 
borderline selenium results in depressed GSHPx, which 
protects  cells  from  lipid  peroxidation. Experimental 
selenium deficiency  increased lipid peroxide levels
[17] 
and  children  with  lower  red-cell  selenium 
concentrations evidenced decreased lipid peroxidation 
products  after  supplementation  with  selenium
[18]. 
Selenium  deficiency  potentiates  lipid  peroxidation  by 
neurotoxins such as paraquat
[19]. 
  Catalase, which  shares  with  selenium-dependent 
GSHPx  the  role  of  protecting  cells  from 
lipoperoxidation, is lower in the red cells of children 
with  autism
[2].  Combined  depression  of  selenium  and 
catalase  would  be  expected  to  potentiate 
greater lipoxidation in children with autism.  
  The  study  does  not  confirm  an  earlier  report  of 
significantly  lower  red-cell  zinc  in  children  with 
autism
[7]. The data demonstrate only a statistical trend 
(p  =0.08) towards  lower  red-cell  zinc. Further  studies 
with  expanded  numbers  of  subjects  are  desirable  in 
order  to  clarify  zinc  status  in  autism,  given  the 
important role  of  zinc  in preventing  lipoxidation  of 
biomolecules.  
  Low zinc status definitely associates with increased 
tissue,  mitochondrial  and  cell  membrane 
peroxidation
[20,21].  In  zinc  deficiency,  unchecked  free 
radicals  increase  cleavage  of  copper  from  MT,  with 
resultant  lipid  peroxidation  and  apoptosis
[22].  Zinc 
complexes  with  phospholipids  to  block  oxidation  of 
fatty  membranes
[5,20]  and  blocks  peroxidation  of 
polyunsaturated lipids unbound to membranes
[23]. Zinc Am. J. Biochem. & Biotech., 4 (2): 101-104, 2008 
 
  103 
supplementation  can  reverse  this  process,  decreasing 
lipid  peroxides  in  both  diabetic  and  elder  human 
models
[24,25].  It  is  undetermined  whether  zinc 
supplementation  in  subjects  with  low  or  borderline 
selenium  and  normal  zinc  levels  enjoy  reduction  in 
lipoxidation.  
  While  inadequate  dietary  intake  is  an  obvious 
possible  explanation  for  depressed  red-cell 
concentrations,  toxic  influences--or  oxidative  stress 
itself--should not be discounted as modulaters of trace 
mineral levels. In fetal alcohol syndrome, for instance, 
excess  free  radical  production  increases  demand  for 
antioxidant enzyme production, resulting in a net deficit 
in selenium and zinc relative to requirements
[26-28]. 
  Higher (double) red-cell molybdenum (p = 0.01) is 
a  tentative  new  finding, for  which  we  find  no 
immediate context in the autism literature. 
 
ACKNOWLEDGEMENTS 
 
  The Autism Research Institute funded this study. 
The  authors  are  independent  health  practitioners  and 
researchers  with  no  commercial  affiliations,  nor 
financial conflicts of interest. 
 
REFERENCES 
 
1.  Cornish, E., 2002. Gluten and casein free diets in 
autism: a study of the effects on food choice and 
nutrition. J. Hum. Nutr. Dietet., 15: 261-269.  
2.  Zoroglu, S.S., F. Armutcu, S. Ozen, A Gurel, E. 
Sivasli, O. Yetkin and I. Meram, 2004. Increased 
oxidative stress and altered activities of erythrocyte 
free  radical  scavenging  enzymes  in  autism.  Eur. 
Arch. Psychiatry. Clin. Neurosci., 254: 143-147.  
3.  Golse, B., P. Debray-Ritzen, P. Durosay, K. Puget 
and A.M. Michelson, 1978. Perturbation de deux 
enzymes;  la  superoxide-dismutaseI  et  la 
glutathione-peroxydase dans la psychose infantile 
de  developpement  (autisme  infantile).  Rev. 
Neurol., 134: 699-705.  
4.  Yorbik, O., A. Sayal, C. Akay, D.I. Akbiyik and T 
Sohmen,  2002.  Investigation  of  antioxidant 
enzymes  in  children  with  autistic  disorder. 
Prostaglandins,  Leukotrienes  and  Essential  Fatty 
Acids, 67: 341-343.  
5.  Ruz, M., K.R. Cavan, W.J. Bettger, P.W. Fischer 
and R.S. Gibson, 1992. Indices of iron and copper 
status  during  experimentally  induced,  marginal 
zinc deficiency in humans. Biol. Trace Elem. Res., 
34: 197-212.  
6.  Isaacson,  H.R.,  M.M.  Moran  and  A.  Hall,  1992. 
Autism: a retrospective outcome study of nutrient 
therapy. J. Appl. Nutr., 48: 110-118. 
7.  Audhya,  T.  and  W.  McGinnis,  2004.  Nutrient, 
toxin  and  enzyme  profile  of  autistic  children. 
International  Meeting  for  Autism  Research 
(IMFAR), Sacramento CA, May 7-8, pp: 74. 
8.  Chen, Y. and W. Maret, 2001. Catalytic selenols 
couple  the  redox  cycles  of  metallothionein  and 
glutathione. Eur. J. Biochem., 268: 3346-3353. 
9.  Holben, D.H. and A.M. Smith, 1999. The diverse 
role of selenium within selenoproteins: A review. J. 
Am. Diet Assoc., 99: 836-843. 
10.  Whanger,  P.D.,  2001.  Selenium  and  the  brain:  a 
review. Nutr. Neurosci., 4: 81-97.  
11.  McGinnis, W.R., 2004. Oxidative stress in autism. 
Alt. Thera. Hlth. Med., 10: 22-37. 
12.  Chauhan,  A.  and  V.  Chauhan,  2006.  Oxidative 
stress in autism. Pathophysiology, 13: 171-181.  
13.  Kern,  J.K.  and  A.M.  Jones,  2006.  Evidence  of 
toxicity,  oxidative  stress  and  neuronal  insult  in 
autism. J. Toxicol. Environ. Hlth., 9: 485-99. 
14.  James, S.J., S. Melnyk, S. Jernigan, M.A. Cleves, 
C.H. Halsted, D.H. Wong, P. Cutler, K. Bock, M. 
Boris,  J.J.  Bradstreet,  S.M.  Baker  and  D.W. 
Gaylor,  2006.  Metabolic  endophenotype  and 
related  genotypes  are  associated  with  oxidative 
stress in children with autism. Am. J. Med. Genet. 
B Neuropsychiatr. Genet., 141: 947-956. 
15.  Ming,  X.,  T.P.  Stein,  M.  Brimacombe,  W.H. 
Johnson,  G.H.  Lambert  and  G.C.  Wagner,  2005. 
Prostaglandins Leukot Essent Fatty Acids, 73: 379-
384. 
16.  Yao,  Y.,  W.J.  Walsh,  W.R.  McGinnis  and  D 
Pratico,  2006.  Altered  vascular  phenotype  in 
autism:  correlation  with  oxidative  stress.  Arch. 
Neurol., 63: 1161-1164.  
17.  Vanderlelie,  J.,  K.  Venardos  and  A.V.  Perkins, 
2004.  Selenium  deficiency  as  a  model  of 
experimental pre-eclampsia in rats. Reproduction, 
128: 635-41.  
18.  Wilke, B.C., M. Vidailet and A. Favier et al., 1992. 
Selenium,  glutathione  peroxidase  (GSH-Px)  and 
lipid  peroxidation  products  before  and  after 
selenium supplementation. Clin. Chim. Acta, 207: 
137-42. 
19.  Glass, M., M.W. Sutherland and H.J. Forman et al. 
Selenium  deficiency  potentiates  paraquat-induced 
lipid peroxidation in isolated perfused rat lung, 59: 
619-22. 
20.  Cunnane, S.C., 1988. Role of zinc in lipid and fatty 
acid  metabolism  and  in  membranes.  Prog.  Food 
Nutr. Sci., 12: 151-188. 
 Am. J. Biochem. & Biotech., 4 (2): 101-104, 2008 
 
  104 
21.  Powell, S.R., 2000. The antioxidant properties of 
zinc. J. Nutr., 130: 1447S-1454S. 
22.  Liu, A, K. Kawai, V.A. Tyurin, Y.Y. Tyurina, G.G. 
Borisenko, J.P. Fabisiak, P.J. Quinn, B.R. Pitt and 
V.E.  Kagan,  2001.  Nitric  oxide-dependent  pro-
oxidant  and  pro-apoptotic  effect  of 
metallothioneins  in  HL-60  cells  challenged  with 
cupric nitrilotriacetate. Biochem. J., 354: 397-406.  
23.  Peterson, D.A., J.M. Gerrard, J. Peller, G.H. Rao 
and  J.G.  White,  1981.  Interactions  of  zinc  and 
arachadonic acid. Prostaglandins Med., 6: 91-99. 
24.  Faure,  P.,  P.Y.  Benhamou,  A.  Perard,  S.  Halimi 
and  A.M.  Roussel,  1995.  Lipid  peroxidation  in 
insulin-dependent  diabetic  patients  with  early 
retina degenerative lesions: effects of an oral zinc 
supplementation. Eur. J. Clin. Nutr., 49: 282-288. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25.  Fortes,  C.,  N.  Agabiti,  V.  Fano,  R.  Pacifici,  F. 
Forastiere, F. Virgili, P. Zuccaro, C.A. Perruci and 
S.  Ebrahim,  1997.  Zinc  supplementation  and 
plasma  lipid  peroxides  in  an  elderly  population. 
Eur. J. Clin. Nutr., 51: 97-101. 
26.  Mendelson,  R.A.  and  A.M.  Huber,  1979.  The 
effect of ethanol consumption on trace elements in 
the fetal rat. Curr. Alcohol, 7: 39-48.  
27.  Zidenberg-Cherr, S., P.A. Benak, L.S. Hurley and 
C.L.  Keen,  1988.  Altered  mineral  metabolism:  a 
mechanism underlying the fetal alcohol syndrome 
in rats. Drug Nutr. Interact., 5: 257-274.  
28.  Dreosti,  I.E.,  1984.  Interactions  between  trace 
elements and alcohol in rats. Ciba Found Symp., 
105: 103-123. 
 